Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Myofibroma × estradiol, norethindrone drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 5 Leiomyoma 5 Myofibroma 1

Interventions

Misoprostol 3 relugolix 2 ramosetron 1 estradiol, norethindrone drug combination 1 Tranexamic Acid 1 Saline Solution 1 Dinoprostone 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03751124 2024-06-25

Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Myovant Sciences GmbH

Phase 3 Completed

229 enrolled 66 charts

Leiomyoma, Menorrhagia, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡